EUVIMEDEUVIMED entdecken
Crossref

From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors

Shiying Zhang, Anli Zhang, Bin Sun iD

Chemical Biology & Drug Design · 2025

DOI: 10.1111/cbdd.70207 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Biology & Drug Design, 2025. Verfasst von Shiying Zhang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, People's Republic of China. Hauptthemen laut MEDLINE: Indoleamine-Pyrrole 2,3,-Dioxygenase, Enzyme Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 31 Literaturangaben. Gefördert von: Natural Science Joint Foundation of Shandong Province, Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Indoleamine 2,3‐dioxygenase‐1 (IDO‐1), as a crucial immunomodulatory target, plays a pivotal role in regulating immune function. In this study, the ligand‐based pharmacophore model (HDAA) and the receptor‐based pharmacophore model (HHDA) were respectively constructed, which could comprehensively reflect the spatial distribution characteristics of the core groups of IDO‐1 inhibitors. Subsequently, these pharmacophore models were utilized to guide the design of novel IDO‐1 inhibitors through a skeleton combination approach. The corresponding molecular structures were synthesized, and evaluated for their biological activities. Notably, compound 7b exhibited highly potent IDO‐1 inhibitory activity, which contributed to the body's immune activation in vivo. In summary, the study not only constructed the rational pharmacophore and docking models but also guided the development of novel IDO‐1 inhibitor skeletons, providing a promising approach to achieving immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Indoleamine-Pyrrole 2,3,-DioxygenaseEnzyme InhibitorsMolecular Docking SimulationAnimalsHumansStructure-Activity RelationshipMiceDrug DesignLigandsPharmacophore

Stichwörter der Autor:innen

activity evaluationdrug designorganic synthesispharmacophore model

Substanzen

Indoleamine-Pyrrole 2,3,-DioxygenaseEnzyme InhibitorsIDO1 protein, humanLigands

Autor:innen und Institutionen

  • Institute of BioPharmaceutical Research, Liaocheng University, Liaocheng, People's Republic of China.

ORCID-Profile: Bin Sun

Förderung

  • Natural Science Joint Foundation of Shandong Province
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Zhang, S., Zhang, A., & Sun, B. (2025). From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors. Chemical Biology & Drug Design. https://doi.org/10.1111/cbdd.70207

Vancouver

Zhang S, Zhang A, Sun B. From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors. Chemical Biology & Drug Design. 2025. doi:10.1111/cbdd.70207

BibTeX
@article{Zhang2025,
  author = {Zhang, Shiying and Zhang, Anli and Sun, Bin},
  title = {From Pharmacophore Models to Lead Compounds: Construction and Activity Evaluation of Novel Indoleamine 2,3‐Dioxygenase‐1 Inhibitors},
  journal = {Chemical Biology & Drug Design},
  year = {2025},
  doi = {10.1111/cbdd.70207}
}
Kostenlos starten →